作者
G. Marra,Federico Lesma,Gabriele Montefusco,Claudia Filippini,Jonathan Olivier,Andres Affentranger,Josias Bastian Grogg,Thomas Hermanns,Luca Afferi,Christian D. Fankhauser,Agostino Mattei,Bartosz Małkiewicz,Simone Scuderi,Francesco Barletta,Sebastian Gallina,Alessandro Antonelli,Fabio Zattoni,Fabrizio Moro,Wever Lieke,Timo Soeterik,Roderick C.N. van den Bergh,Paweł Rajwa,Shahrokh F. Shariat,Lara Rodríguez‐Sánchez,Rossella Nicoletti,Riccardo Campi,Mohamed Ahmed,R. Jeffrey Karnes,Michael Ladurner,Isabel Heidegger,Alberto Briganti,Paolo Gontero,Giorgio Gandaglia
摘要
More than 10% of patients with negative clinical metastatic status (cN0M0) on conventional imaging for prostate cancer (PCa) harbor lymph node involvement (pN+) at final pathology following radical prostatectomy (RP) and lymphadenectomy. Our aim was to assess outcomes of initial observation for cN0M0 pN+ PCa and identify prognostic factors that may help in clinical decision-making.